John S. Penta
Impact in
- Clinical Biochemistry top 5%
- Metabolism and Genetic Disorders
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
Papers in
-
- Cancer therapeutics and mechanisms 4
- Mitochondrial Function and Pathology 3
- Oncology 7
- Cancer Treatment and Pharmacology 3
- Co-authors
- William C. Copeland (3 shared papers)J. T. Wachsman (3 shared papers)F. M. Johnson (3 shared papers)Daniel D. Von Hoff (4 shared papers)Salvador Bruno (7 shared papers)Lee J. Helman (2 shared papers)M Slavík (1 shared paper)Franco M. Muggia (8 shared papers)
- Journals
- Recent results in cancer research (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Mutation Research/Reviews in Mutation Research (1 paper)The Journal of Clinical Pharmacology (1 paper)Cancer Treatment Reviews (1 paper)
- Partner nations
- United StatesMalaysiaItaly
In The Last Decade
John S. Penta
26 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 110
- Clinical Biochemistry 103
- Cancer Research 227
- Molecular Biology 605
- Oncology 161
- Statistics and Probability 42
Countries citing papers authored by John S. Penta
This map shows the geographic impact of John S. Penta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Penta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Penta more than expected).
Fields of papers citing papers by John S. Penta
This network shows the impact of papers produced by John S. Penta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Penta. The network helps show where John S. Penta may publish in the future.
Co-authors
The 25 scholars most cited alongside John S. Penta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 376 | |
| 2 | 2002 | 184 | |
| 3 | Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration. | 1977 | 102 |
| 4 | 1981 | 69 | |
| 5 | Animal toxicology for early clinical trials with anticancer agents. | 1981 | 47 |
| 6 | Treatment of cancer chemotherapy-induced nausea and vomiting | 1981 | 35 |
| 7 | 1979 | 31 | |
| 8 | Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule. | 1992 | 27 |
| 9 | Acivicin. An antitumor antibiotic. | 1981 | 27 |
| 10 | 1992 | 25 | |
| 11 | 1981 | 21 | |
| 12 | Adequacies and inadequacies in assessing murine toxicity data with antineoplastic agents. | 1979 | 19 |
| 13 | Current status of chemotherapy in the treatment of advanced carcinoma of the thyroid gland. | 1981 | 16 |
| 14 | 1982 | 16 | |
| 15 | 1977 | 16 | |
| 16 | Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agents. | 1977 | 13 |
| 17 | The hypoxic cell sensitizer programme in the United States. | 1978 | 13 |
| 18 | 2003 | 10 | |
| 19 | 1976 | 9 | |
| 20 | 1980 | 6 |
About John S. Penta
John S. Penta is a scholar working on Molecular Biology, Oncology, Cancer Research, Surgery and Pulmonary and Respiratory Medicine, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (4 papers), Metabolism and Genetic Disorders (3 papers), Cancer Treatment and Pharmacology (3 papers), Acute Lymphoblastic Leukemia research (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Statistical Methods in Clinical Trials (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Mitochondrial Function and Pathology (3 papers). The work is most often cited by research in Clinical Biochemistry (103 citations), Cancer Research (227 citations), Molecular Biology (605 citations), Oncology (161 citations) and Statistics and Probability (42 citations). John S. Penta has collaborated with scholars based in United States, Malaysia and Italy. Frequent co-authors include William C. Copeland, J. T. Wachsman, F. M. Johnson, Daniel D. Von Hoff, Salvador Bruno, Lee J. Helman, M Slavík, Franco M. Muggia, Raymond B. Weiss and Marcel Rozencweig. Their work appears in journals such as Recent results in cancer research, Cancer Chemotherapy and Pharmacology, Mutation Research/Reviews in Mutation Research, The Journal of Clinical Pharmacology and Cancer Treatment Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.